Shilpa Gupta

Dr. Joshua Meeks, a urologist at Northwestern University, and Dr. Shilpa Gupta, a medical oncologist at Cleveland Clinic, dive into the intricacies of managing non-muscle invasive bladder cancer (NMIBC). They explore the definition of high-risk NMIBC and discuss groundbreaking clinical trials like CREST and POTOMAC, focusing on immunotherapy innovations. The duo emphasizes the need for a collaborative approach between urologists and oncologists, addresses the challenges of side effects from treatment, and highlights patient-centered discussions in this rapidly evolving field.